GLP-1 medication used in the polyendocrine metabolic ovarian syndrome trial Friday, July 10, 2026 in Aurora, Colo. (AP Photo/Brittany Peterson)

News, Photo and Web Search

Other Photos

Previous Photo

Next Photo